Colon Polyps Clinical Trial
— COLDWATEROfficial title:
Randomized Clinical Trial to Compare Underwater Cold Snare Polypectomy (UCSP) to Conventional Cold Snare Polypectomy (CCSP) for Non Pedunculated Colon Polyps of Size 5-10mm [COLDWATER Study]
NCT number | NCT05273697 |
Other study ID # | PN61759 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 21, 2022 |
Est. completion date | July 15, 2023 |
Verified date | November 2023 |
Source | National and Kapodistrian University of Athens |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Colon cancer is internationally the third cause of deaths from a malignant disease. Screening colonoscopy in adults >45 years of age aims at the early diagnosis and treatment colon polyps that are precancerous lesions. Endoscopic polyp removal (polypectomy) can be done with various techniques depending on the size, morphology, location of the polyp etc. According to updated guidelines, non-pedunculated polyps of small size are treated with a cold snare in air dilated intestinal lumen (conventional cold snare polypectomy - CCSP).In recent years, several studies have described the benefits of water aided colonoscopy, as well as safety and efficacy of underwater polypectomy in large colon polyps. However, there is not enough data on small polyps which are the most commonly diagnosed.This is a prospective randomized double-blind clinical trial to compare the safety and efficacy of CCSP to underwater cold snare polypectomy (UCSP)for non-pedunculated polyps of size of 5-10 mm. A total of 398 polyps will be randomized and randomization will be performed via random numbers method of Microsoft Excel 2016. Primary outcome of this study is to determine muscularis mucosa resection rate. Secondary outcomes are the depth and percentage of R0 excisions and possible complications. The investigators expect UCSP to ensure a higher muscularis mucosa resection rate and they attempt to examine the resection depth in the submucosal layer.These results will provide useful data for the development of guidelines in polypectomy techniques for non-pedunculated polyps 5-10mm.
Status | Completed |
Enrollment | 396 |
Est. completion date | July 15, 2023 |
Est. primary completion date | June 11, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years and older |
Eligibility | Inclusion Criteria: 1. Age > 20years 2. Non pedunculated polyps (Paris classification Isp, Is, IIa, IIb) 3. Polyp size: diameter of 5 to 10mm 4. Endoscopic diagnosis of mucosal lesions - must not present malignant submucosal infiltration evidence like deepening, ulceration / ulcer, abnormal vessels, irregular surface, (NICE 1, NICE 2A, BASIC) 5. Informed consent 6. Patients who receive antiplatelet / anticoagulant therapy are included in the study only if their therapy has been modified according to ESGE guidelines Exclusion Criteria: 1. Age <20 years old 2. Pedunculated polyps 3. Lesions with macroscopic elements of high-grade dysplasia or submucosal infiltration 4. Sites with previous polypectomy 5. Patients with idiopathic inflammatory bowel disease 6. Patients with coagulation disorders 7. Patients with severe organ failure 7.Patients who during endoscopy will undergo any technique using electrocautery / electrocoagulation will not be eligible for participation in the study. |
Country | Name | City | State |
---|---|---|---|
Greece | Sismanogleio General Hospital | Athens |
Lead Sponsor | Collaborator |
---|---|
National and Kapodistrian University of Athens |
Greece,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | percentage of muscularis mucosa included in specimen (%) | Determination of percentage of muscularis mucosa included in specimen. The determination of the percentage of the area containing muscularis mucosa layer will be done by measuring the length of muscularis mucosa mm / length of specimen mm x100%. Using an ocular and stage micrometer, the length of the muscularis mucosa underlining a neoplastic lesion was measured, along with the specimen's maximum diameter (mm) | through study completion, an average of 1 year | |
Secondary | Presence or absence of submucosal in the specimen and its depth (if present) | Presence or absence of submucosa
- Measurement of submucosa depth in µm (when submucosa is present in the specimen) |
through study completion, an average of 1 year | |
Secondary | Percentage of R0 Resections | Vial 1 : Determination of polypectomy margin according to Residual Tumor Classification Vial 1A : Determination of horizontal margins: presence of residual damage or not In order to determine the horizontal margins, 2-4 biopsies will be taken from the resection area (2 biopsies antidiametrically in polyps of 5-7 mm size, 4 biopsies in polyps of 8-10 mm size). One cup of forceps will be placed in the defect and the second in the macroscopically normal mucosa.
The received tissue pieces will be placed in a new vial with formol (Vial 1A) A microscopically margin-negative resection will be characterized as "R0 resection" The determination of R0 Resection Rate will be done by measuring the number of R0 resections / number of all the resections regardless R classification |
through study completion, an average of 1 year | |
Secondary | Complication rate | intraprocedural bleeding, post-procedural bleeding, perforation, abdominal pain not due to perforation. These complications will be evaluated by a study physician of the Gastroenterology Department with a phone call and clinical examination if needed | 30 days after the polypectomy (treatment procedure) | |
Secondary | Recurrence lesion rate during repeat colonoscopy in 6-12months | A subgroup of the sample size will undergo a follow up colonoscopy in 6-12 months in order to identify lesion recurrence | 6-12 months after polypectomy (treatment procedure) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT01214031 -
Prospective Study for Evaluating Colon Polyp Histology With in Vivo Probe Based Confocal Laser Endomicroscopy
|
N/A | |
Unknown status |
NCT01704820 -
Right Sided Colon Polyp Miss Rate: Impact Of Retroflexion In The Right Colon
|
N/A | |
Completed |
NCT01483040 -
PeerScope B System™ Clinical Protocol
|
N/A | |
Recruiting |
NCT01211132 -
Cap Assisted Colonoscopy for the Detection of Colon Polyps
|
N/A | |
Completed |
NCT00209573 -
A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy
|
Phase 3 | |
Completed |
NCT04666194 -
A Pilot Randomized Trial of Polypectomy Techniques for 4-6 mm Colonic Polyps
|
N/A | |
Completed |
NCT00417001 -
Reduction of Conscious Sedation Requirements by Olfactory Stimulation
|
N/A | |
Active, not recruiting |
NCT03735953 -
Retroflexion in the Entire Colon for the Detection of Colon-related Diseases
|
N/A | |
Recruiting |
NCT02332785 -
Prospective Study of Colon Serrated Polyps
|
||
Completed |
NCT02325635 -
A Prospective Trial of an Endoscopic Quality Improvement Project
|
N/A | |
Completed |
NCT01487356 -
Factors Associated With Short Withdrawal Time and Polyp Detection Rate During Colonoscopy
|
N/A | |
Completed |
NCT00467922 -
An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy
|
Phase 3 | |
Completed |
NCT01986699 -
Laparascopic Assisted Colonoscopic Polypectomy
|
N/A | |
Completed |
NCT02156557 -
Study of KCC Peptide Application in the Colon
|
Phase 1 | |
Enrolling by invitation |
NCT02097394 -
The Clinical Study on Combizym and Bifidobacteri to Prevent the Recurrence of Colon Polyps
|
Phase 4 | |
Completed |
NCT00492193 -
Early Post-Op Recovery After Partial Large Bowel Resection
|
N/A | |
Completed |
NCT00825292 -
Detection and Classification of Colon Polyps
|
Phase 2 | |
Completed |
NCT02665741 -
Comparison of Colon Adenoma Detection Rate Using Two Distal Colonoscope Attachments
|
N/A | |
Completed |
NCT02665299 -
Plasma ctDNA in Patients Undergoing Diagnostic Colonoscopy
|
N/A | |
Completed |
NCT02635217 -
Same Day Bidirectional Endoscopies - Does the Sequence of Procedures or Choice of Insufflator Matter?
|
N/A |